Valuation: Shivalik Rasayan Limited

Market Cap 4.79B 50.54M 45.16M 41.47M 37.69M 70.82M 72.59M 494M 199M 2.53B 190M 186M 8.02B P/E 2025
59.1x
P/E 2026 28.2x
Enterprise Value 5.67B 59.88M 53.5M 49.13M 44.65M 83.89M 86M 586M 236M 2.99B 225M 220M 9.51B EV / Sales 2025
3.4x
EV / Sales 2026 1.21x
Free-Float
46.1%
Yield 2025
0.08%
Yield 2026 0.23%
08-14 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors CI
05-27 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-27 Shivalik Rasayan Limited Announces Resignation of Sanjay Bansal as Non-Executive Director, Effective May 27, 2026 CI
05-27 Shivalik Rasayan Limited Recommends Final Dividend for the Financial Year 2025-26, Payable on or After October 15, 2026 CI
05-27 Shivalik Rasayan Ltd March-quarter consol net profit 45.3 million rupees RE
02-13 Shivalik Rasayan Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Shivalik Rasayan Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
29/09/25 Shivalik Rasayan Limited Approves the Re-Designation of Mr. Ashwani Kumar Sharma as a Non-Executive, Non-Independent Director CI
12/08/25 Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 Shivalik Rasayan Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
29/05/25 Shivalik Rasayan Limited announces Annual dividend, payable on October 27, 2025 CI
23/04/25 Medicamen Biotech Limited announced that it has received INR 535.6816 million in funding from Kim Ginnerup ApS, Shivalik Rasayan Limited, VERALOGIX HOLDINGS LTD and other investors CI
1 day+2.41%
1 week-2.20%
Current month+1.50%
1 month-22.56%
3 months+23.08%
6 months+16.34%
Current year-14.57%
1 week 282.2
Extreme 282.2
320.95
1 month 282.2
Extreme 282.2
399.9
Current year 206
Extreme 206
437.9
1 year 206
Extreme 206
474.2
3 years 206
Extreme 206
873.6
5 years 206
Extreme 206
1,196.8
10 years 75.4
Extreme 75.4
1,196.8
Manager TitleAgeSince
Chief Executive Officer 64 16/11/2018
Director of Finance/CFO - 31/10/2001
Compliance Officer - 31/07/2017
Director TitleAgeSince
Chairman 62 22/02/2002
Director/Board Member 67 17/07/2003
Director/Board Member - 12/11/2018
Date Insider Type Main position Quantity % Market Cap. Importance
01/07/24 Don 21,500 0.1382%
26/06/24 Sell 108,500 0.6973%
Change 5-day change 1-year change 3-year change Capi.($)
+2.41%-2.20%-31.19%-55.89% 49.39M
-1.15%+1.26%+27.07%+27.57% 33.54B
-2.93%-3.33%+40.24%+45.43% 18.21B
+2.69%+1.12%-9.31%+35.56% 17.42B
-0.26%+2.43%-7.02%-14.75% 14.48B
+0.11%-.--%-.--%-.--% 12.96B
-1.87%-4.51%+5.01%+5.44% 10.85B
-0.78%-8.27%-6.49%+137.66% 9.06B
-0.22%-.--%-.--%-.--% 8.3B
-0.34%-0.59% - - 7.95B
Average -0.23%-0.29%+2.03%+20.11% 13.28B
Weighted average by Cap. -0.60%+0.82%+10.98%+27.72%

Financials

2025 2026
Net sales 3.1B 32.68M 29.19M 26.81M 24.36M 45.78M 46.93M 320M 129M 1.63B 123M 120M 5.19B 3.62B 38.17M 34.1M 31.32M 28.46M 53.48M 54.83M 373M 150M 1.91B 143M 140M 6.06B
Net income 167M 1.76M 1.57M 1.45M 1.31M 2.47M 2.53M 17.24M 6.94M 88.06M 6.62M 6.47M 280M 124M 1.31M 1.17M 1.07M 976K 1.83M 1.88M 12.8M 5.16M 65.4M 4.91M 4.81M 208M
Net Debt 768M 8.1M 7.24M 6.65M 6.04M 11.35M 11.64M 79.26M 31.92M 405M 30.41M 29.76M 1.29B 884M 9.33M 8.34M 7.66M 6.96M 13.08M 13.41M 91.3M 36.77M 466M 35.03M 34.28M 1.48B
Projected Income Statement - Annual - Shivalik Rasayan Limited
Logo Shivalik Rasayan Limited
Shivalik Rasayan Limited is an India-based company. The Company’s segments are engaged in agrochemicals, active pharma ingredients (API), and pharma formulation. It is the producer of Malathion Technical and Dimethoate Technical. Malathion Technical is a non-systemic, wide spectrum organophosphorus (OP) based contact insecticide. Dimethoate Technical is used in preparation of formulations used in the control of a range of insects and mites. It also manufactures organophosphorus-based insecticides and chemicals. It has a diverse product range and product mix in order to serve consumer requirements. The APIs are being developed and manufactured in the niche area of oncology, ARVs, cardiovascular, metabolic disorders and immunology. It offers solutions from product selection to development to commercialization for a range of oncology and non-oncology products. The Company’s oncology products include Azacitidine, Busulfan, Bortezomib, and various others.
Employees
342
Date Price Change Volume
03/11/26 ₹304.00 +2.41% 11,256
02/11/26 ₹296.85 -0.88% 4,837
30/10/26 ₹299.50 -4.13% 7,486
29/10/26 ₹312.40 -1.01% 2,904
28/10/26 ₹315.60 -1.67% 915
  1. Stock Market
  2. Stocks
  3. SHIVALIK Stock